Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayer B Davidson

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Diabetes Care|June 29, 2004
Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority populationRajiv Roy, Maria Navar, Gladys Palomeno, et al.
Diabetes Care|November 25, 2003
Lowering the criterion for impaired fasting glucose will not provide clinical benefitMayer B Davidson, Pamela B Landsman, Charles M Alexander
The American Journal of Medicine|April 6, 2005
The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trialMayer B Davidson, Maria Castellanos, Don Kain, et al.
Diabetes Care|May 30, 2006
Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetesMichael T Tran, Maria D Navar, Mayer B Davidson
Clinical Diabetes : a Publication of the American Diabetes Association|February 1, 2018
Comparison of Insulin Dose Adjustments by Primary Care Physicians and EndocrinologistsMayer B Davidson, Petra Duran, S Joshua Davidson, et al.
Diabetes Care|November 14, 2009
U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patientsMayer B Davidson, Maria D Navar, Diana Echeverry, et al.
Diabetes Care|September 5, 2009
Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trialDiana Echeverry, Petra Duran, Curley Bonds, et al.
Diabetes Care|October 27, 2006
Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patientsPiya Ballani, Michael T Tran, Maria D Navar, et al.
Journal of Diabetes|October 2, 2019
Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot studyStanley H Hsia, Petra Duran, Martin L Lee, et al.
Journal of the National Medical Association|December 4, 2003
The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority populationDiana M Echeverry, Margie R Dike, Courtney Washington, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Diabetes Care|June 29, 2004
Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority populationRajiv Roy, Maria Navar, Gladys Palomeno, et al.
Diabetes Care|November 25, 2003
Lowering the criterion for impaired fasting glucose will not provide clinical benefitMayer B Davidson, Pamela B Landsman, Charles M Alexander
The American Journal of Medicine|April 6, 2005
The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trialMayer B Davidson, Maria Castellanos, Don Kain, et al.
Diabetes Care|May 30, 2006
Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetesMichael T Tran, Maria D Navar, Mayer B Davidson
Clinical Diabetes : a Publication of the American Diabetes Association|February 1, 2018
Comparison of Insulin Dose Adjustments by Primary Care Physicians and EndocrinologistsMayer B Davidson, Petra Duran, S Joshua Davidson, et al.
Diabetes Care|November 14, 2009
U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patientsMayer B Davidson, Maria D Navar, Diana Echeverry, et al.
Diabetes Care|September 5, 2009
Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trialDiana Echeverry, Petra Duran, Curley Bonds, et al.
Diabetes Care|October 27, 2006
Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patientsPiya Ballani, Michael T Tran, Maria D Navar, et al.
Journal of Diabetes|October 2, 2019
Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot studyStanley H Hsia, Petra Duran, Martin L Lee, et al.
Journal of the National Medical Association|December 4, 2003
The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority populationDiana M Echeverry, Margie R Dike, Courtney Washington, et al.
Pageof 15